Trial intelligence / Profile preview

Fluticasone Propionate vs N-acetylcysteine in COPD

NCT00184977Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Dec 1998
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine, fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by Radboud University Medical Center. Started Dec 1998; status: completed.

02

Drugs

acetylcysteinefluticasone propionate
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00184977.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00184977.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call